Latency period | | |
None | | |
Time-dependent ICS exposure# | 1.20 (1.02–1.40) | 0.024 |
Recency-weighted duration of use¶ | 1.19 (1.11–1.28) | <0.001 |
6 months | | |
Time-dependent ICS exposure | 0.91 (0.78–1.05) | 0.197 |
Recency-weighted duration of use | 0.97 (0.89–1.05) | 0.476 |
1 year+ | | |
Time-dependent ICS exposure | 0.70 (0.61–0.80) | <0.001 |
Recency-weighted duration of use | 0.74 (0.66–0.82) | <0.001 |
2 years | | |
Time-dependent ICS exposure | 0.32 (0.28–0.37) | <0.001 |
Recency-weighted duration of use | 0.31 (0.26–0.37) | <0.001 |
Cohort (age ≥65 years) | | |
Time-dependent ICS exposure | 0.66 (0.56–0.77) | <0.001 |
Recency-weighted duration of use | 0.70 (0.62–0.79) | <0.001 |